Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:30:57 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Q:HZNP - HORIZON THERAPEUTICS PLC - http://www.horizonpharma.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HZNP - QHALTED116.30    116.38  60.0303Oct 05Oct 0615 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2023-10-06 08:30U:HZNPNews ReleaseRule 17(e) Announcement - Horizon Therapeutics plc
2023-10-05 07:40U:HZNPNews ReleaseRule 17(d) Announcement ¢ € “ Horizon Therapeutics plc
2023-10-03 11:15U:HZNPNews ReleaseRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
2023-10-02 11:39U:HZNPNews ReleaseRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
2023-10-02 08:00U:HZNPNews ReleaseHorizon Therapeutics plc Announces New UPLIZNA ‚ ® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
2023-09-29 11:45U:HZNPNews ReleaseRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
2023-09-29 10:00U:HZNPNews ReleaseNew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA ‚ ® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes
2023-09-27 09:45U:HZNPNews ReleaseRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
2023-09-26 09:02U:HZNPNews ReleaseHorizon Therapeutics plc Named to U.S. News & World Report ¢ € ™s 2024 List of Best Companies to Work For in the Health Care Industry
2023-09-25 09:34U:HZNPNews ReleaseRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
2023-09-19 08:00U:HZNPNews ReleaseHorizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List
2023-09-13 08:00U:HZNPNews ReleaseQ32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata
2023-09-06 16:15U:HZNPNews ReleaseHorizon Therapeutics plc ( ¢ € œHorizon ¢ € ) Rule 2.12 Announcement
2023-09-05 09:05U:HZNPNews ReleaseHorizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement
2023-09-01 09:20U:HZNPNews ReleaseAmgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition
2023-08-23 08:00U:HZNPNews ReleaseHorizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups